Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ADXN
  4. Conagra Brands, Inc. (CAG) Q1 2026 Earnings Call Prepared Remarks Transcript

Conagra Brands, Inc. (CAG) Q1 2026 Earnings Call Prepared Remarks Transcript

ADXN logo
ADXN
Addex Therapeutics Ltd
6.21 USD
0.00%

Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

Overview

Despite some positive elements like debt reduction and service levels, the overall sentiment is negative due to declining sales, margins, and EPS. Inflation, weak consumer sentiment, and higher tariff costs are significant concerns. The Q&A section did not provide clarity, adding uncertainty. The expectation of declining sales in Q2 and lower operating margins further contribute to the negative outlook. The impact of divestitures and foreign exchange headwinds exacerbates the situation, leading to a likely negative stock price movement in the short term.

Key Financial Performance

Organic Net Sales $2.6 billion, a 0.6% decline year-over-year. The decline was driven by a 1.2% decrease in volumes, partially offset by a 0.6% increase in price/mix. Foreign exchange was a 10 basis point headwind, and divestitures had a 510 basis point impact.

Adjusted Gross Margin 24.4%, down 244 basis points year-over-year. This was due to elevated inflation (approximately 7%), unfavorable product mix, and lower internal production volumes.

Adjusted Operating Margin 11.8%, down 244 basis points year-over-year. The decline was driven by unfavorable product mix, inflation, and lower internal production volumes, partially offset by productivity gains and tariff mitigation.

Adjusted Earnings Per Share (EPS) $0.39, down $0.14 year-over-year. The decline was due to lower adjusted operating profit, a higher adjusted tax rate, and reduced profit from divested businesses, partially offset by higher pension income and lower interest expense.

Net Debt Reduction Reduced by over $400 million in Q1, driven by proceeds from divestitures. Compared to the year-ago period, net debt was reduced by nearly $1.1 billion.

Service Levels Achieved 98% service levels, ensuring product availability. This was a key success story for the supply chain in Q1.

Productivity Gains Exceeded 5% of cost of goods sold, driven by core productivity programs and tariff mitigation.

Capital Expenditures $147 million in Q1, in line with the prior year.

Dividends Paid $167 million in Q1, in line with the prior year.

Free Cash Flow Impacted by seasonal working capital build and inventory rebuilding from recent supply constraints.

You have reached the limit. Sign up to access full content
Get started

Operating Highlights

Frozen Portfolio: Volumes improved 3.2 points in Q1 compared to Q4 fiscal '25, with share gains in frozen vegetables, meals, and prepared chicken.

Snacks Business: Meat snacks grew by 4% and seeds by 2%. However, Angie’s BOOMCHICKAPOP declined 19% due to promotional timing shifts, and Duncan Hines saw an 8% decline due to pricing elasticity.

Staples Portfolio: Hebrew National recovered from prior out-of-stocks, and volume share gains were noted in chili, tomatoes, and whipped toppings.

Divestitures: Completed divestitures of Chef Boyardee, Van de Kamp's, and Mrs. Paul's, using proceeds to reduce net debt by over $400 million.

International Segment: Organic net sales declined 3.5% due to elasticity-related volume declines despite price increases.

Supply Chain Performance: Achieved 98% service levels and delivered productivity gains exceeding 5% of cost of goods sold.

Debt Reduction: Reduced net debt by $1.1 billion year-over-year, with net leverage at 3.55x.

Capital Allocation: Investing $450 million in CapEx for fiscal '26 and maintaining a $1.40 annual dividend rate.

Pricing Strategy: Targeted pricing actions in canned products and select Sweet Treats to address sustained cocoa inflation.

You have reached the limit. Sign up to access full content
Get started

Risk or Challenges

Inflationary Pressure: Persistent inflation, particularly in animal proteins (beef, pork, turkey), steel, aluminum, and tariffs, has increased costs beyond initial expectations, impacting margins and financial performance.

Weak Consumer Sentiment: Ongoing weak consumer sentiment and value-seeking behavior are affecting demand and pricing elasticity, particularly in categories like Sweet Treats and staples.

Tariff Costs: Higher-than-expected tariff costs, especially related to steel, aluminum, and China, are adding to cost pressures, with mitigation efforts only partially offsetting the impact.

Supply Chain Modernization: Modernization projects, such as the baked chicken facility, are causing transitory sourcing and absorption headwinds, impacting operating margins in the short term.

Pricing Elasticity: Price increases in response to inflation, particularly in Sweet Treats and canned products, are leading to volume declines due to consumer sensitivity to pricing.

Divestitures Impact: The divestiture of businesses like Chef Boyardee and frozen seafood has reduced net sales and profit contributions, impacting overall financial performance.

Foreign Exchange Headwinds: Foreign exchange fluctuations have negatively impacted net sales, particularly in the International segment.

Operating Leverage: Lower internal production volumes have resulted in unfavorable operating leverage, further pressuring margins.

You have reached the limit. Sign up to access full content
Get started

Guidance & Outlook

Fiscal 2026 Guidance: Reaffirmed fiscal '26 guidance with expectations for organic net sales growth of -1% to +1%, adjusted operating margin of approximately 11% to 11.5%, and adjusted EPS of $1.70 to $1.85.

Inflation and Tariffs: Core inflation is now expected to be slightly higher than the original 4% estimate, primarily due to increased costs in animal proteins. Total inflation is projected to be in the low 7% range, up from the previous estimate of approximately 7%. Tariff exposure remains at approximately 3% of cost of goods sold, with some country-specific tariff rates increasing.

Capital Expenditures: Planned capital expenditures for fiscal '26 remain at approximately $450 million, consistent with initial expectations.

Dividend and Shareholder Returns: The company expects to maintain its $1.40 annual dividend rate and continues to focus on balanced capital allocation.

Supply Chain Modernization: The baked chicken facility modernization project is expected to be completed in Q2, with benefits realized in the second half of fiscal '26.

Second Quarter Expectations: Organic net sales are expected to decline in the low single digits due to recent consumption trends and a shift in trade expense to Q2. Operating margin for Q2 is expected to be moderately below the full-year range due to higher net tariff costs and trade timing.

Full-Year Inflation and Productivity: Full-year inflation is expected to be in the low 7% range, slightly higher than the original projection. This increase is expected to be offset by higher productivity and tariff mitigation.

Cash Tax Payments: Fiscal '26 cash tax payments are expected to be favorable by approximately $75 million due to recently passed legislation.

Tax Rate and Interest Expense: The full-year tax rate is now expected to be approximately 24%, up from 23%. Interest expense is expected to be approximately $390 million, down from the prior estimate of $400 million.

You have reached the limit. Sign up to access full content
Get started

Shareholder Return Plan

Annual Dividend Rate: $1.40 per share

Dividends Paid in Q1: $167 million

Share Repurchase in Q1: $15 million worth of shares repurchased to offset dilution from share-based incentive compensation plans

You have reached the limit. Sign up to access full content
Get started

Key Q&A

Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started

Earnings Word Cloud

The most frequently occurring keywords in this quarter's earning call
CFO
Chef Boyardee
Director Investor
Investor Relations
Senior Director
Slide portfolio
Today
approach capital
behavior
brand
capital allocation
category
chicken
cocoa
consumer domain
consumer sentiment
debt
environment
expectation
inflation
level
line
outlook
pricing action
product
productivity
recovery
service
share
shift
snack
supply chain
tariff
timing
volume

ADXN Transcript

Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Transcript
Neutral6-25
Addex Therapeutics Ltd (ADXN) Q4 2025 Earnings Call Transcript
Unknown4-30

The earnings call lacked critical financial details such as revenue, margins, and cash flow, making it difficult to assess financial performance. While there were positive operational updates on drug development, potential regulatory and strategic execution risks were highlighted. The absence of strategic initiatives, shareholder return plans, and financial metrics limits the ability to predict strong market movement. Without additional insights from the Q&A, the sentiment remains neutral.

Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript
Unknown12-4

The earnings call reflects a mixed outlook. The financial performance remains stable, but with increased liabilities and reliance on partnerships, there's uncertainty. The Q&A reveals concerns about competitive pressures and funding needs. Positive aspects include potential milestone payments and strategic repositioning of programs. However, the lack of specific guidance and increased liabilities weigh down sentiment, leading to a neutral stock price prediction.

Conagra Brands, Inc. (CAG) Q1 2026 Earnings Call Prepared Remarks Transcript
Unknown10-1

Despite some positive elements like debt reduction and service levels, the overall sentiment is negative due to declining sales, margins, and EPS. Inflation, weak consumer sentiment, and higher tariff costs are significant concerns. The Q&A section did not provide clarity, adding uncertainty. The expectation of declining sales in Q2 and lower operating margins further contribute to the negative outlook. The impact of divestitures and foreign exchange headwinds exacerbates the situation, leading to a likely negative stock price movement in the short term.

ADXN Report

Addex Therapeutics Ltd. 6-K
6-K
2025-06-25
Addex Therapeutics Ltd. 6-K
6-K
2024-11-22
Addex Therapeutics Ltd. 6-K
6-K
2024-09-19
Addex Therapeutics Ltd. 6-K
6-K
2024-06-06

Frequently Asked Questions

Where does this earnings call transcript come from?

All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.

How soon is the transcript available after the earnings call ends?

Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.

Is the transcript edited or altered in any way?

No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.

Why do some answers appear as “Unclear” or “Inaudible”?

When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.

Who creates the AI Summary and Key Q&A highlights shown above the transcript?

They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.

Explore More Earnings

PENG logo
PENG
2026-07-07 16:05:00
after hour
After Hours
Revenue
$478.71M
+10.05%
EPS
-$0.71
+12.70%
AI Prediction
-
AI Summary
Calendar ReportReport
KRUS logo
KRUS
2026-07-07 16:06:00
after hour
After Hours
Revenue
$85.92M
-0.40%
EPS
-$0.03
+160.00%
AI Prediction
-
AI Summary
Calendar ReportReport
SAR logo
SAR
2026-07-07 16:24:00
after hour
After Hours
Revenue
$30.78M
-2.82%
EPS
-$0.47
-12.96%
AI Prediction
-
Calendar ReportReport
EPAC logo
EPAC
2026-07-07 17:04:00
after hour
After Hours
Revenue
$167.55M
+1.86%
EPS
-$0.60
+22.45%
AI Prediction
-
Calendar ReportReport
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia